TARS
Tarsus Pharmaceuticals Inc
74.10$
-0.5%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 96.6% | 96.5% | 97.6% | 96.2% | 94.9% | 94.6% | 96.0% | 95.8% | 93.9% | 93.0% | 92.4% | 92.0% | |
| 84.5% | 84.7% | 55.5% | 48.1% | 46.8% | 25.2% | 35.1% | 19.5% | 21.1% | 32.7% | 17.6% | 33.5% | |
| 92.0% | 85.7% | 85.5% | 85.9% | 84.2% | 77.3% | 81.5% | 77.0% | 75.2% | 74.2% | 66.9% | 73.6% | |
| 2.4% | 6.7% | 9.0% | 8.2% | 8.1% | 12.7% | 12.8% | 12.2% | 13.9% | 15.5% | 20.2% | 16.1% | |
| 0.0% | 1.2% | 1.2% | 0.6% | 0.8% | 0.7% | 0.5% | 0.8% | 0.7% | 0.8% | 0.8% | 0.7% | |
| 1.5% | 1.5% | 1.1% | 1.0% | 2.3% | 2.2% | 1.6% | 1.6% | 1.4% | 1.3% | 1.2% | 1.1% | |
| 20.4% | 25.8% | 21.2% | 33.1% | 36.9% | 40.4% | 31.6% | 32.8% | 37.3% | 38.9% | 40.0% | 43.3% | |
| 8.7% | 13.9% | 12.2% | 13.7% | 17.5% | 21.4% | 17.2% | 18.2% | 21.9% | 24.1% | 24.7% | 28.8% | |
| 0.2% | 0.1% | 0.2% | 0.2% | 0.2% | 0.2% | 0.1% | 0.1% | 0.0% | – | – | – | |
| 3.9% | 6.7% | 5.5% | 7.1% | 7.1% | 7.4% | 5.7% | 5.7% | 7.6% | 2.9% | 4.2% | 6.6% | |
| 11.1% | 11.2% | 8.6% | 19.0% | 19.1% | 19.1% | 14.4% | 14.6% | 13.5% | 12.9% | 12.5% | 11.9% | |
| 79.6% | 74.2% | 78.8% | 66.9% | 63.1% | 59.6% | 68.4% | 67.2% | 62.7% | 61.1% | 60.0% | 56.7% | |
| -75.6% | -92.2% | -80.3% | -83.2% | -89.6% | -95.5% | -77.0% | -82.0% | -78.2% | -75.9% | -74.6% | -74.0% | |
| 11.4% | 12.0% | 10.1% | 10.0% | 10.2% | 10.2% | 7.9% | 8.6% | 8.0% | 7.6% | 7.4% | 7.1% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.